Company / AR per Share
LENZ Therapeutics, Inc. AR per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.01
FY2025
5-year range
$0.01 / $0.01
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#107 of 113
Health Care
What the data says
Among 113 Health Care companies, LENZ Therapeutics, Inc. is in the bottom 5% for ar per share.
Based on SEC 10-K filings.
0.01 in FY2025.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 113This company $0.01 Sector average $28.83
▼
-100.0% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026